Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment | ||
| dc.conicet.organizacion | Laval University | |
| dc.conicet.organizacion | Laval University | |
| dc.conicet.organizacion | Laval University | |
| dc.conicet.organizacion | Laval University | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Física de Buenos Aires. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Física de Buenos Aires | |
| dc.conicet.organizacion | Laval University | |
| dc.contributor.author | Villeneuve, Jérôme | |
| dc.contributor.author | Galarneau, Hugo | |
| dc.contributor.author | Beaudet, Marie Josée | |
| dc.contributor.author | Tremblay, Pierrot | |
| dc.contributor.author | Chernomoretz, Ariel | |
| dc.contributor.author | Vallières, Luc | |
| dc.date.issued | 2008-07 | |
| dc.description.abstract | All patients with glioblastoma, the most aggressive and common form of brain cancer, develop cerebral edema. This complication is routinely treated with dexamethasone, a steroidal anti-inflammatory drug whose effects on brain tumors are not fully understood. Here we show that dexamethasone can reduce glioma growth in mice, even though it depletes infiltrating T cells with potential antitumor activity. More precisely, T cells with helper or cytotoxic function were sensitive to dexamethasone, but not those that were negative for the CD4 and CD8 molecules, including gammadelta and natural killer (NK) T cells. The antineoplastic effect of dexamethasone was indirect, as it did not meaningfully affect the growth and gene expression profile of glioma cells in vitro. In contrast, hundreds of dexamethasone-modulated genes, notably angiopoietin 2 (Angpt2), were identified in cultured cerebral endothelial cells by microarray analysis. The ability of dexamethasone to attenuate Angpt2 expression was confirmed in vitro and in vivo. Selective neutralization of Angpt2 using a peptide-Fc fusion protein reduced glioma growth and vascular enlargement to a greater extent than dexamethasone, without affecting T cell infiltration. In conclusion, this study suggests a mechanism by which dexamethasone can slow glioma growth, providing a new therapeutic target for malignant brain tumors. © 2008 The Authors. | es |
| dc.description.fil | Fil: Villeneuve, Jérôme. Laval University; Canadá | |
| dc.description.fil | Fil: Galarneau, Hugo. Laval University; Canadá | |
| dc.description.fil | Fil: Beaudet, Marie Josée. Laval University; Canadá | |
| dc.description.fil | Fil: Tremblay, Pierrot. Laval University; Canadá | |
| dc.description.fil | Fil: Chernomoretz, Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Física de Buenos Aires. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Física de Buenos Aires; Argentina | |
| dc.description.fil | Fil: Vallières, Luc. Laval University; Canadá | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Villeneuve, Jérôme; Galarneau, Hugo; Beaudet, Marie Josée; Tremblay, Pierrot; Chernomoretz, Ariel; et al.; Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment; Wiley Blackwell Publishing, Inc; Brain Pathology; 18; 3; 7-2008; 401-414 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1015-6305 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/62173 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 3 | es |
| dc.journal.pagination | 401-414 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Brain Pathology | es |
| dc.journal.volume | 18 | es |
| dc.language.iso | eng | es |
| dc.publisher | Wiley Blackwell Publishing, Inc | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.1111/j.1750-3639.2008.00139.x | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1750-3639.2008.00139.x | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ | * |
| dc.subject | Angiopoietin-2 | es |
| dc.subject | Antitumor Immunity | es |
| dc.subject | Gene Profiling | es |
| dc.subject | Glioblastoma | es |
| dc.subject | Glucocorticoid | es |
| dc.subject | Tumor Endothelium | es |
| dc.subject.classification | Otras Ciencias Biológicas | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.35293d38-60ae-4f3a-bcf1-b23bdb2e30cc_A.pdf
- Tamaño:
- 1.24 MB
- Formato:
- Adobe Portable Document Format